A New Hepatitis C Treatment: No Interferon or Ribavirin Required!
Harvoni Takes the Sting Out of Hepatitis C Treatment
For the first time, hepatitis C can be cured without interferon and ribavirin, which can cause fatigue and depression.
Written by David Heitz | October 26, 2014
Finally, there’s a medication to cure hepatitis C that doesn’t require use of the dreaded drugs interferon or ribavirin.
The U.S. Food and Drug Administration earlier this month approved Harvoni, a once-daily tablet manufactured by Gilead Sciences. Harvoni is a combination medication that includes sofosbuvir (Sovaldi), another Gilead breakthrough treatment approved late last year, and ledipasvir, which is also made by Gilead.
Continue reading this entire article:
How Can Chronic Pain Lead to Hepatitis C?
Harvoni Is Here: The Once-a-Day, Single Hep C Pill